4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-22-000137
Chief R&D Officer gave up 286 shares (to pay taxes)
- Chief R&D Officer acquired 1,150 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scopelianos Angelo Chief R&D Officer | 2022-12-27 | Option exercise | +1,150 | 26,244 | D | ||
| Scopelianos Angelo Chief R&D Officer | 2022-12-27 | Shares withheld for taxes | −286 | $9.44 | $2,700 | 25,958 | D |
| Derivatives | |||||||
| Scopelianos Angelo Chief R&D Officer | 2022-12-27 | Option exercise · Restricted Stock Units | +1,150 | 0 | D | ||
Loading xslF345X03/wf-form4_167236440298967.xml…